User:nellhhew361285
Jump to navigation
Jump to search
New data demonstrate that Lecanemab , a investigational monoclonal antibody , could slow the advance of preclinical dementia . This medication works by removing amyloid
https://www.targetmol.com/compound/nadecnemab